NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
InspireMD, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.44−0.02 (-3.34%)
Close on Oct 19, 2026
- Market cap
- $37.25M
- P/E (TTM)
- –
- Dividend yield
- –
InspireMD statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | InspireMD | Industry median |
|---|---|---|
| Market Cap | $20.46M | $230.55M |
| Enterprise Value | -$9.97M | $202.97M |
| PS Ratio | 1.89 | 3.11 |
| PB Ratio | 0.65 | 3.14 |
| P/TBV Ratio | 0.65 | 4.57 |
Enterprise value
| Measure | InspireMD | Industry median |
|---|---|---|
| EV / Sales | -0.92 | 2.92 |
Income (trailing twelve months)
| Measure | InspireMD | Industry median |
|---|---|---|
| Revenue | $10.84M | $102.39M |
| Gross Profit | $1.96M | $60.36M |
| Operating Income | -$53.56M | -$4.31M |
| Net Income | -$52.48M | -$6.57M |
| EBITDA | -$53.56M | -$1.98M |
Margins
| Measure | InspireMD | Industry median |
|---|---|---|
| Gross Margin | 18.1% | 55.1% |
| Operating Margin | -494.0% | -6.04% |
| Profit Margin | -484.1% | -10.5% |
| EBITDA Margin | -494.0% | -2.67% |
| FCF Margin | -391.7% | -0.30% |
Returns
| Measure | InspireMD | Industry median |
|---|---|---|
| Return on Equity (ROE) | -202.8% | -19.2% |
| Return on Assets (ROA) | -134.6% | -13.3% |
| Return on Invested Capital (ROIC) | -4319.6% | -4.11% |
| Return on Capital Employed (ROCE) | -153.0% | -9.07% |
Growth
| Measure | InspireMD | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 53.4% | 8.85% |
| Revenue Growth (3Y CAGR) | 20.2% | 7.08% |
| Revenue Growth (5Y CAGR) | 29.3% | 11.8% |
Balance sheet
| Measure | InspireMD | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $30.42M | $37.33M |
| Net Cash (Debt) | $30.42M | $3.92M |
| Net Cash Per Share | $0.65 | $0.28 |
| Equity (Book Value) | $31.51M | $57.36M |
| Book Value Per Share | $0.68 | $2.81 |
| Tangible Book Value | $31.51M | $10.71M |
| Working Capital | $26.98M | $54.64M |
Financial position
| Measure | InspireMD | Industry median |
|---|---|---|
| Current Ratio | 3.80 | 2.50 |
| Quick Ratio | 3.34 | 1.54 |
Cash flow (trailing twelve months)
| Measure | InspireMD | Industry median |
|---|---|---|
| Operating Cash Flow | -$41.21M | -$653.46K |
| Capital Expenditures | -$1.25M | -$3.69M |
| Free Cash Flow | -$42.46M | -$835.02K |
| FCF Per Share | -$0.91 | -$0.02 |
Efficiency
| Measure | InspireMD | Industry median |
|---|---|---|
| Asset Turnover | 0.28 | 0.59 |
| Inventory Turnover | 3.09 | 2.21 |
| Revenue Per Employee | $85.36K | $322.57K |
| Profits Per Employee | -$413.24K | -$51.88K |
| Employee Count | 127 | 185 |
Dividends and yields
| Measure | InspireMD | Industry median |
|---|---|---|
| Earnings Yield | -256.6% | -6.91% |
| FCF Yield | -207.6% | -0.56% |
Shares
| Measure | InspireMD | Industry median |
|---|---|---|
| Shares Outstanding | 46,489,100 | 44,856,700 |
| Shares Change (YoY) | 63.2% | 3.35% |
| Shares Change (QoQ) | 0.18% | 0.27% |
| Float | 31,796,600 | 37,097,900 |
| Shares Held by Insiders | 31.6% | 10.6% |
| Shares Held by Institutions | 53.6% | 63.5% |
Scores
| Measure | InspireMD | Industry median |
|---|---|---|
| Altman Z-Score | -12.42 | 1.95 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -3.37 | -2.64 |
Calculated by StockData from InspireMD's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.